Gene · 10457
Papers2,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Insights into Parkinson's Disease Progression: A Multi-omics Analysis of the Substantia Nigra Pars Compacta across Braak Stages. | Exp Neurobiol | 2026 | 42130054 | PubTator, text mining | PubMed |
| Secreted GPNMB enhances uptake of fibrillar alpha-synuclein in a non-cell-autonomous process that can be blocked by anti-GPNMB antibodies. | Neuron | 2026 | 42127911 | PubTator, text mining | PubMed |
| Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1. | Biomark Res | 2026 | 42106890 | PubTator, text mining | PubMed |
| Glycoprotein Nonmetastatic B⁺ Myeloid-Derived Suppressor Cells Mediate Radiation-Induced Immune Suppression in Prostate Cancer and Are Targetable to Improve Systemic Control. | Int J Radiat Oncol Biol Phys | 2026 | 42069260 | PubTator, text mining | PubMed |
| Integrated Proteomics Reveal ALDH1A1 as an Oncogenic Driver and Regulatory Hub in Hepatocellular Carcinoma. | Cancer Genomics Proteomics | 2026 | 42055623 | PubTator, text mining | PubMed |
| Morphology spectrum and molecular landscape in eosinophilic solid and cystic renal cell carcinoma. | Hum Pathol | 2026 | 42055232 | PubTator, text mining | PubMed |
| Identification of serum protein biomarkers in individuals with Niemann-Pick disease, type C1. | Res Sq | 2026 | 42052237 | PubTator, text mining | PubMed |
| Renal tumors harboring FLCN mutations: Case series from clinical practice. | Hum Pathol | 2026 | 42000053 | PubTator, text mining | PubMed |
| Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model. | Proc Natl Acad Sci U S A | 2026 | 41980098 | PubTator, text mining | PubMed |
| [Clinicopathological features of TSC/mTOR mutation-associated renal cell carcinoma with leiomyomatous stroma: report of nine cases]. | Zhonghua Bing Li Xue Za Zhi | 2026 | 41956743 | PubTator, text mining | PubMed |
| IL-4/IL-4Rα signaling activates PPARγ to promote oligodendrocyte differentiation and remyelination. | Brain Behav Immun | 2026 | 41935645 | PubTator, text mining | PubMed |
| FLCN-mutated oncocytic tumor in the thyroid defines a biologically distinct subset characterized by metabolic remodeling and canonical oncogenic signaling suppression. | Virchows Arch | 2026 | 41925849 | PubTator, text mining | PubMed |
| TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances. | Cancers (Basel) | 2026 | 41899560 | PubTator, text mining | PubMed |
| Dermal Exposure to Heavy Metals in Urban Green Space Soils: A Review of Bioavailability, Toxic Mechanisms, and Precision Risk Assessment. | Toxics | 2026 | 41893504 | PubTator, text mining | PubMed |
| Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma. | Med Sci (Basel) | 2026 | 41892825 | PubTator, text mining | PubMed |
| 3D pentaculture model unveils malignant cell-driven macrophage polarization in high-grade serous ovarian cancer. | Nat Commun | 2026 | 41881987 | PubTator, text mining | PubMed |
| Vitreoretinal Myeloid Cell Heterogeneity: Diverse Roles in Homeostasis, Immune Surveillance, and Pathophysiology. | J Immunol | 2026 | 41876369 | PubTator, text mining | PubMed |
| Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures. | Cell | 2026 | 41875888 | PubTator, text mining | PubMed |
| A single-cell and spatial transcriptomic atlas of human tuberculous constrictive pericardium. | EBioMedicine | 2026 | 41875497 | PubTator, text mining | PubMed |
| IFRD1 orchestrates hepatocyte metabolism and macrophage interactions to facilitate liver regeneration. | J Hepatol | 2026 | 41861961 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10457/papers?page=4